Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic
2006
Abstract
Analyses of hematopoietic stem cell transplantation (SCT) results are of high importance for decision-making on treatment strategy for patiens with SCT as a possible therapeutic alternative. In this paper the Czech National Registry of SCT and Transplantation Center in Pilsen present their joint retrospective analysis of the results of allogeneic SCT in patiens with chronic myeloid leukemia (CML) performed in the Czech Republic from 1988 to 2005. 295 patients ranging in age from 6,9 to 59,5 years (median 37,3) underwent transplants.
It can be concluded that results of allogeneic SCT in CML in the Czech Republic reflect current global trends, are comparable with results achieved in other countries and show significant improvements.